The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the phase Ib study of ipilimumab and gemcitabine for advanced pancreas cancer.
 
Nisha Anjali Mohindra
No Relationships to Disclose
 
Sheetal Mehta Kircher
No Relationships to Disclose
 
Halla Sayed Nimeiri
Speakers' Bureau - Genentech
 
Al B. Benson
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Genomic Health; Gilead Sciences; Lilly/ImClone; Merck; Novartis; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals
Research Funding - Advanced Accelerator Applications (Inst); Alchemia (Inst); Amgen (Inst); Astellas Pharma (Inst); AVEO (Inst); Genentech (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Novartis (Inst)
 
Alfred Rademaker
Research Funding - Siemens (Inst)
 
Erin Alonso
No Relationships to Disclose
 
Nicole Blatner
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
 
Khashayarsha Khazaie
No Relationships to Disclose
 
Mary Frances Mulcahy
Research Funding - Bristol-Myers Squibb (Inst); BTG (Inst)